Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.

Bartek J Jr, Alattar AA, Dhawan S, Ma J, Koga T, Nakaji P, Dusenbery KE, Chen CC.

J Neurooncol. 2019 Oct;145(1):75-83. doi: 10.1007/s11060-019-03268-y. Epub 2019 Aug 30.

PMID:
31471790
2.

Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.

Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen CC.

J Neurosurg. 2018 Apr;128(4):1076-1083. doi: 10.3171/2016.11.JNS161974. Epub 2017 May 12.

PMID:
28498059
3.

Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.

Schupper AJ, Hirshman BR, Carroll KT, Ali MA, Carter BS, Chen CC.

World Neurosurg. 2017 Jul;103:741-747. doi: 10.1016/j.wneu.2017.03.140. Epub 2017 Apr 16.

PMID:
28419878
4.

Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.

Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC.

Brachytherapy. 2019 Jan - Feb;18(1):29-37. doi: 10.1016/j.brachy.2018.08.016. Epub 2018 Oct 22.

PMID:
30361045
5.

Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.

Acharya S, Perkins SM, DeWees T, Fischer-Valuck BW, Mutch DG, Powell MA, Schwarz JK, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):649-57. doi: 10.1016/j.ijrobp.2015.06.013. Epub 2015 Jun 15.

PMID:
26461007
6.

Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.

Alattar AA, Carroll KT, Bryant AK, Hirshman B, Joshi R, Carter BS, Harismendy O, Chen CC.

World Neurosurg. 2019 Jan;121:e411-e418. doi: 10.1016/j.wneu.2018.09.124. Epub 2018 Sep 26.

PMID:
30266697
7.

Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.

Adams H, Adams HH, Jackson C, Rincon-Torroella J, Jallo GI, Qui├▒ones-Hinojosa A.

Childs Nerv Syst. 2016 Mar;32(3):493-503. doi: 10.1007/s00381-015-3006-x. Epub 2016 Jan 15.

PMID:
26767842
8.

Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis.

Rao YJ, Hui C, Chundury A, Schwarz JK, DeWees T, Powell MA, Mutch DG, Grigsby PW.

Brachytherapy. 2017 Jul - Aug;16(4):831-840. doi: 10.1016/j.brachy.2017.03.012. Epub 2017 May 19.

PMID:
28533162
9.

Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.

Padwal JA, Dong X, Hirshman BR, Hoi-Sang U, Carter BS, Chen CC.

World Neurosurg. 2016 Jun;90:186-193. doi: 10.1016/j.wneu.2016.02.078. Epub 2016 Feb 24.

PMID:
26924115
10.

Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection.

Carroll KT, Bryant AK, Hirshman B, Alattar AA, Joshi R, Gabel B, Carter BS, Harismendy O, Vaida F, Chen CC.

World Neurosurg. 2018 Mar;111:e790-e798. doi: 10.1016/j.wneu.2017.12.165. Epub 2018 Jan 5.

PMID:
29309983
11.

Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.

Nwachukwu CR, Von-Eyben R, Kidd EA.

Brachytherapy. 2018 Mar - Apr;17(2):383-391. doi: 10.1016/j.brachy.2017.11.001. Epub 2017 Dec 2.

PMID:
29198879
12.

Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.

Hou WH, Schultheiss TE, Wong JY, Wakabayashi MT, Chen YJ.

Int J Gynecol Cancer. 2018 Jan;28(1):188-193. doi: 10.1097/IGC.0000000000001143.

PMID:
29206662
13.

Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.

Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen CC.

J Neurosurg. 2014 Jan;120(1):31-9. doi: 10.3171/2013.9.JNS13877. Epub 2013 Nov 8.

PMID:
24205904
14.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
15.

Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.

Reddy AK, Ryoo JS, Denyer S, McGuire LS, Mehta AI.

Neurosurg Focus. 2019 Jun 1;46(6):E3. doi: 10.3171/2019.3.FOCUS1971.

PMID:
31153148
16.

Brachytherapy improves survival in primary vaginal cancer.

Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D.

Gynecol Oncol. 2016 Jun;141(3):501-506. doi: 10.1016/j.ygyno.2016.03.011. Epub 2016 Apr 1.

PMID:
27036631
17.

Adjuvant Pelvic Radiation Therapy┬▒Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.

Nagar H, Yan W, Parashar B, Nori D, Chao KS, Christos P, Gupta D, Holcomb K, Caputo T, Wernicke AG.

Am J Clin Oncol. 2016 Aug;39(4):335-9. doi: 10.1097/COC.0000000000000065.

PMID:
27028349
18.

Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.

Huang H, Muscatelli S, Naslund M, Badiyan SN, Kaiser A, Siddiqui MM.

J Urol. 2019 Jan;201(1):120-128. doi: 10.1016/j.juro.2018.07.049.

PMID:
30059685
19.

Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy of Gleason 9-10 Prostate Cancer.

Muralidhar V, Mahal BA, Butler S, Lamba N, Yang DD, Leeman J, D'Amico AV, Nguyen PL, Trinh QD, Orio PF 3rd, King MT.

J Urol. 2019 May 30:101097JU0000000000000352. doi: 10.1097/JU.0000000000000352. [Epub ahead of print]

PMID:
31144590
20.

Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.

Trifiletti DM, Alonso C, Grover S, Fadul CE, Sheehan JP, Showalter TN.

World Neurosurg. 2017 Jul;103:330-340. doi: 10.1016/j.wneu.2017.04.035. Epub 2017 Apr 17.

PMID:
28427986

Supplemental Content

Support Center